CHAD explores sleep, distribution agreements
CHATSWORTH, Calif. -- CHAD Therapeutics said last week that it was talking to several distributors about formalizing distribution agreements for its Total O2 oxygen transfilling system. Sales of Total 02 jumped 62% in FY 2005 over the previous year.
CHAD also reported in its year-end earnings news that its new sleep device -- the particulars of which have yet to be disclosed -- reduced the amount of air pressure needed to treat sleep apnea patients. The new device uses proprietory sensor technology. CHAD expects to make decisions about how to distribute the new sleep product this summer.
CHAD'S revenues increased by 2% to $5.4 million for the fourth quarter. Year-end revenues increased more substantially, by 12% over the previous year to $24.3 million.
While CHAD's international conserver sales boomed by 51% last year, the company eked out 5% growth in the domestic market. CHAD CEO Earl Yager characterized the domestic conserver market as uncertain.